Veit Gülberg Selected Research

Veit Gülberg Research Topics

6	Fibrosis (Cirrhosis) 05/2008 - 01/2002
3	Hepatorenal Syndrome 11/2011 - 05/2008
3	Ascites 01/2005 - 01/2002
2	Body Weight (Weight, Body) 04/2010 - 04/2003
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2019
1	Hepatic Encephalopathy 05/2019
1	Neoplasms (Cancer) 04/2016
1	Thyroid Nodule (Nodule, Thyroid) 04/2016
1	Myocardial Infarction 05/2008
1	Peritonitis 11/2007
1	Hypertension (High Blood Pressure) 01/2005
1	Pulmonary Hypertension 01/2005
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2005
1	Familial Primary Pulmonary Hypertension 01/2005
1	Portal Hypertension 01/2005
1	Hyponatremia 04/2003

2	TerlipressinIBA 09/2009 - 05/2008
2	Vasoconstrictor AgentsIBA 05/2008 - 01/2005
1	Indicators and Reagents (Reagents)IBA 04/2016
1	ThromboxanesIBA 04/2010
1	Xanthine OxidaseIBA 04/2010
1	gadolinium chlorideIBA 04/2010
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 04/2010
1	salicylhydroxamic acid (SHAM)IBA 04/2010
1	XanthineIBA 04/2010
1	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 04/2010
1	Reagent StripsIBA 11/2007
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 05/2007
1	SodiumIBA 05/2007
1	Endothelin Receptor AntagonistsIBA 01/2005
1	BilirubinIBA 01/2005
1	Bosentan (Tracleer)FDA Link 01/2005
1	Endothelins (Endothelin)IBA 01/2005
1	Endothelin-1 (Endothelin 1)IBA 01/2005
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 04/2003
1	Vasopressins (Vasopressin)IBA 04/2003
1	lixivaptanIBA 04/2003
1	Antidiuretic Hormone Receptor AntagonistsIBA 04/2003
1	BuffersIBA 03/2002

3	Therapeutics 05/2019 - 04/2003
3	Transjugular Intrahepatic Portasystemic Shunt 01/2005 - 01/2002
2	Liver Transplantation 11/2011 - 01/2005
1	Ligation 04/2010
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2002